LEXEO THERAPEUTICS INC (LXEO) Stock Balance Sheet
NASDAQ:LXEO - Nasdaq - US52886X1072 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 28.91M | 121.47M | 77.30M | 135.90M | 29.40M | |||
| Marketable Securities | 70.92M | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 5.44M | 2.83M | 2.70M | 800.00K | 0.00 | |||
| Total Current Assets | 105.27M | 124.29M | 80.00M | 136.70M | 29.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 10.13M | 12.26M | 13.80M | 200.00K | 0.00 | |||
| Investments And Advances | 7.04M | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 3.25M | 3.25M | 3.30M | 0.00 | 0.00 | |||
| Total Non-Current Assets | 20.42M | 15.51M | 17.10M | 200.00K | 0.00 | |||
| TOTAL ASSETS | 125.69M | 139.81M | 97.10M | 136.90M | 29.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 521.00K | 518.00K | 500.00K | N/A | N/A | |||
| Accrued Expenses | 17.65M | 12.60M | 10.40M | 3.80M | 300.00K | |||
| Accounts Payable | 11.98M | 3.79M | 2.70M | 3.10M | 0.00 | |||
| Other Current Liabilities | 669.00K | 326.00K | 700.00K | 600.00K | 400.00K | |||
| Total Current Liabilities | 30.82M | 17.24M | 14.30M | 7.40M | 700.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 698.00K | 1.25M | 1.60M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 6.05M | 7.79M | 9.00M | 0.00 | 3.00M | |||
| Total Non-Current Liabilities | 6.75M | 9.03M | 10.70M | 0.00 | 3.00M | |||
| TOTAL LIABILITIES | 37.58M | 26.27M | 25.00M | 7.40M | 3.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -312.83M | -181.84M | -115.40M | -56.20M | -5.50M | |||
| Additional Paid In Capital | 401.01M | 295.37M | 2.50M | 600.00K | 0.00 | |||
| Common Shares | 3.00K | 3.00K | 185.00M | 185.00M | 31.20M | |||
| Treasury Stock | -17.00K | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | -54.00K | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 33.19M | 26.67M | 24.70M | 24.70M | 24.70M | |||
| Tangible Book Value per Share | 2.65 | 4.26 | -4.57 | -2.25 | -0.22 | |||
| Total Shareholders' Equity | 88.11M | 113.53M | 72.10M | 129.40M | 25.70M | |||
| TOTAL LIABILITIES AND EQUITY | 125.69M | 139.81M | 97.10M | 136.90M | 29.40M | |||
| Statistics | ||||||||
| Debt/Equity | 0.01 | 0.01 | 0.02 | N/A | N/A | |||
| Current Ratio | 3.42 | 7.21 | 5.59 | 18.47 | 42.00 | |||
| Return On Assets (ROA) | -86.97% | -47.49% | -61.05% | -36.98% | -17.52% | |||
| Return On Equity (ROE) | -124.05% | -58.48% | -82.22% | -39.12% | -20.04% | |||
All data in USD , ROIC based on taxRate of 0.21